MARKET

ANGO

ANGO

Angiodynamics
NASDAQ
12.40
+0.03
+0.24%
Opening 13:36 12/09 EST
OPEN
12.29
PREV CLOSE
12.37
HIGH
12.50
LOW
12.25
VOLUME
112.64K
TURNOVER
1.06M
52 WEEK HIGH
30.00
52 WEEK LOW
11.71
MARKET CAP
484.94M
P/E (TTM)
-14.9110
1D
5D
1M
3M
1Y
5Y
A number of insiders bought AngioDynamics, Inc. (NASDAQ:ANGO) stock last year, which is great news for shareholders
Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like...
Simply Wall St. · 11/25 13:29
Why Coupa Software Shares Jumped Around 29%; Here Are 72 Biggest Movers From Wednesday
Benzinga · 11/25 09:52
Credit Suisse, Autodesk And Other Big Losers From Wednesday
Benzinga · 11/25 07:34
BRIEF-Jury Enters Verdict That Certain Of Angiodynamics Inc's Implantable Port Products Infringe Certain U.S. Patents Held By BARD
Reuters · 11/23 21:51
Why PagSeguro Digital Shares Are Trading Lower By 18%? Here Are 40 Stocks Moving In Wednesday's Mid-Day Session
Benzinga · 11/23 18:27
AngioDynamics Disagrees With Jury Decision on Patent-Infringement Verdict, Plans to Appeal
AngioDynamics Disagrees With Jury Decision on Patent-Infringement Verdict, Plans to Appeal
MT Newswires · 11/23 14:03
Company Believes It Has Meritorious Defenses, Positions With Respect To The Matters Remaining To Be Decided And The Jury Decision; - Angiodynamics Intends To Vigorously Pursue All Available Remedies And Defenses, Including Post-Trial Motions And Appeals
Benzinga · 11/23 13:43
On Nov 22, Jury Entered Verdict That Certain Of Co's Implantable Port Products Infringe Certain U.S. Patents Held By Bard; Issue Of Damages Was Bifurcated By Court During Trial, Was Not Determined By Jury And Will Be Subject To A Separate Proceedings
Benzinga · 11/23 13:42
More
About ANGO
AngioDynamics, Inc. is a medical technology company. The Company is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options. It operates through two segments, namely Med Tech and Med Device. Its products offerings fall within three global business units: Endovascular Therapies (VIT), Oncology/Surgery (OS) and Vascular Access (VA). Its products include Auryon, Thrombectomy, Peripheral Products (Core), BioFlo, Midlines, Peripherally Inserted Central Catheter (PICC), C3 Wave PICC tip location system, Ports, Dialysis Products, Venous Insufficiency, Microwave Ablation, Radiofrequency Ablation, BioSentry Tract Sealant System, IsoLoc Endorectal Balloon and Alatus Vaginal Balloon Packing System. Its Thrombus Management portfolio includes the AlphaVac System, AngioVac venous drainage system, Thrombolytic catheters and NanoKnife. Its Peripheral Products (Core) include Angiographic Products and Accessories, Drainage Products and Micro Access Kits.

Webull offers kinds of AngioDynamics, Inc. stock information, including NASDAQ:ANGO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ANGO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ANGO stock methods without spending real money on the virtual paper trading platform.